SEARCH

SEARCH BY CITATION

References

  • 1
    Llovet JM, Vilana R, Bru C, Bianchi L, Salmeron JM, Boix L, Ganau S, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33:11241129.MEDLINE
  • 2
    Kato T, Reddy KR. Radiofrequency Ablation for Hepatocellular Carcinoma: help or hazard? Hepatology 2001; 33:13361337.MEDLINE
  • 3
    Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN. Complications after cool-tip RF ablation of liver cancer: initial report of the Italian multicentre cooled-tip RF study group. Radiology 2000: 217(suppl):27A.
  • 4
    Di Stasi M, Ruscarini L, Livraghi T, Giorgio A, Salmi A, De Sio I, Brunello F, et al. Percutaneous ethanol injection therapy in the treatment of hepatocellular carcinoma—a multicenter survey of evaluation practices and complication rate. Scand J Gastroenterol 1997; 32:11681173.MEDLINE
  • 5
    Gervais DA, Goldberg SN, Arellano RS, Chung R, Mueller PR. Treatment of hepatocellular carcinoma in cirrhotic patients awaiting transplant: a new and evolving use of percutaneous radiofrequency ablation. Presented at 86th Scientific Assembly and Annual Meeting, RSNA Chicago IL, December 2000; 217(P)1664.
  • 6
    McGahan JP, Dodd G III. Radiofrequency ablation of the liver: current status. AJR 2001; 176:316.